CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy President & CEO bought 14,160 shares at $0.89 ($12,659)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy President & CEO bought 8,560 shares at $0.85 ($7,276)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 19 of 27 · 538 filings